0001209191-21-050953.txt : 20210811
0001209191-21-050953.hdr.sgml : 20210811
20210811172025
ACCESSION NUMBER: 0001209191-21-050953
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210809
FILED AS OF DATE: 20210811
DATE AS OF CHANGE: 20210811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosenberg Adam Joseph
CENTRAL INDEX KEY: 0001867407
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40708
FILM NUMBER: 211164634
MAIL ADDRESS:
STREET 1: C/O ELIEM THERAPEUTICS, INC.
STREET 2: 23515 NE NOVELTY HILL RD, STE B221 #125
CITY: REDMOND
STATE: WA
ZIP: 98053
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eliem Therapeutics, Inc.
CENTRAL INDEX KEY: 0001768446
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832273741
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 23515 NE NOVELTY HILL RD., SUITE B221 #1
CITY: REDMOND
STATE: WA
ZIP: 98077
BUSINESS PHONE: 16502240857
MAIL ADDRESS:
STREET 1: 23515 NE NOVELTY HILL RD., SUITE B221 #1
CITY: REDMOND
STATE: WA
ZIP: 98077
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-09
0
0001768446
Eliem Therapeutics, Inc.
ELYM
0001867407
Rosenberg Adam Joseph
C/O ELIEM THERAPEUTICS, INC.
23515 NE NOVELTY HILL RD, STE. B221 #125
REDMOND
WA
98053
1
0
0
0
Stock Option (Right to Buy)
12.50
2021-08-09
4
A
0
20000
0.00
A
2031-08-08
Common Stock
20000
20000
D
For so long as the Reporting Person continuously provides services to the Issuer, this option will vest with respect to the shares as follows: 1/36th of the shares will vest on each monthly anniversary of August 1, 2021.
/s/ Alan Hambelton, Attorney-in-Fact
2021-08-11